Docking Screens for Novel Ligands Conferring New Biology.
about
The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking InvestigationsIn search of novel ligands using a structure-based approach: a case study on the adenosine A2A receptorComputational methods in drug discovery.Identification of Novel Smoothened Ligands Using Structure-Based Docking.An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells.In silico design of novel probes for the atypical opioid receptor MRGPRX2.Role of Structural Bioinformatics in Drug Discovery by Computational SNP Analysis: Analyzing Variation at the Protein Level.Performance of machine-learning scoring functions in structure-based virtual screening.Molecular Modelling Approaches for the Analysis of Histamine Receptors and Their Interaction with Ligands.Modulating the wnt signaling pathway with small molecules.Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor.Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design.Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor.Discovery of new GPCR ligands to illuminate new biology.Predicted Biological Activity of Purchasable Chemical Space.Congestion game scheduling for virtual drug screening optimization.Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point.Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain.Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor.Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening.Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.Medicinal Chemistry Profiling of Monocyclic 1,2-Azaborines.Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (EISA) of Dipeptide Derivatives.Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors.Superior Performance of the SQM/COSMO Scoring Functions in Native Pose Recognition of Diverse Protein–Ligand Complexes in Cognate Docking.Combining Similarity Searching and Network Analysis for the Identification of Active Compounds.Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design
P2860
Q28066944-387E29BD-B068-4CB3-9263-7272E8C3C903Q28820807-AF3DDC94-F915-4720-B906-72488179590DQ30398071-89228835-FEA2-4DBD-8B62-C5D641FBA7C8Q36094653-5A6F1268-471F-4454-8F90-2AA27CEDE3D0Q37210555-BD6574C4-364A-43C3-91E3-E731A0D861E2Q37708769-CA0C2A8F-9125-4733-B54B-A001A1862E82Q38712431-180D50F8-CD82-42BF-877E-30A662A62EA6Q38743935-9EE1F209-05B8-4E40-807E-BCA212BB8BDCQ38821300-A309694D-D252-4A73-99C9-60C8DD7FB557Q39007384-BA626E2B-8C38-47F5-83B8-B03BB89AE0E4Q39102292-324DAC36-78E3-41D7-9C75-18068D985F0BQ41451154-068BD98D-2B7C-498B-97F0-5B0498472174Q41931663-C29F35FF-A52D-4E09-85BA-F0E0D272C974Q42222778-A6000F91-1C85-4562-B35A-136FCF567EB4Q44632467-3FD1A039-693F-4F76-8249-6B6E03F00659Q46344527-55261331-F778-4438-BE01-148E75073A86Q47385721-4E3BE2F7-A91A-46E6-9DAD-617DF668DCFBQ47571750-ECDC6126-3226-4357-A907-6368DCD84CA0Q47626065-AACDA1EC-8406-423D-AE8A-6D0840C64AE4Q48542611-E85FBAE5-3657-4021-AE84-47551202FB93Q49914169-AA0BCF2C-8168-4024-9DF7-EE790C860577Q50089879-86860606-BB77-4E3A-A78A-5AD5EECBB31BQ50128763-14DF359B-B2B1-488A-B5D2-BE048C314C30Q50622600-449E6291-F274-4FA2-B410-67AA828FC311Q50902844-1CE2AE52-04EB-4FD4-91BA-2E25F0330024Q52902179-9D979472-9701-41FA-BB34-91C86B75467AQ55325728-F54DA284-F09F-4352-BA82-57039BA912A4Q55669302-B9CD6878-2B38-4E23-A701-451DDF379FDCQ55669325-D69C08F7-8C3D-47CB-9C66-45CAB9930C17Q57175255-E35722FE-D4E1-4958-AA80-76A680EF5C01
P2860
Docking Screens for Novel Ligands Conferring New Biology.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Docking Screens for Novel Ligands Conferring New Biology.
@ast
Docking Screens for Novel Ligands Conferring New Biology.
@en
type
label
Docking Screens for Novel Ligands Conferring New Biology.
@ast
Docking Screens for Novel Ligands Conferring New Biology.
@en
prefLabel
Docking Screens for Novel Ligands Conferring New Biology.
@ast
Docking Screens for Novel Ligands Conferring New Biology.
@en
P2860
P1476
Docking Screens for Novel Ligands Conferring New Biology.
@en
P2860
P304
P356
10.1021/ACS.JMEDCHEM.5B02008
P407
P577
2016-02-25T00:00:00Z